• Início
  • Referências Bibliográficas

Referências Bibliográficas

Aptamil Profutura:

  1. SBP. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  2. Liu L et al. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res. 2014;55(3):531-9.

  3. Wijendran V et al. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res. 2002;51(3):265-72.

  4. Graf et al. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2010;83(2):89-96.

  5. Pedersen L et al. Polyunsaturated fatty acid content of mother's milk is associated with childhood body composition. Pediatr Res. 2012;72(6):631-6.

  6. Scholtens S et al. Breastfeeding, weight gain in infancy, and overweight at seven years of age: the prevention and incidence of asthma and mite allergy birth cohort study. Am J Epidemiol. 2007;165(8):919-26.

  7. Stahl B et al. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem. 1994;223(2):218-26.

  8. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238–225.

  9. Havlicekova Z et al. Beta-palmitate - a natural component of human milk in supplemental milk formulas. Nutr J. 2016;15(1):28.

  10. Comparativo de produtos de mesma categoria realizada em abril de 2020.

  11. Kabaran S, Besler HT. Do fatty acids affect fetal programming?. J Health Popul Nutr.2015;33:14.

  12. Innis SM. Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr. 2011;7 Suppl 2:112-23.

  13. Mennitti LV et al. Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring. J Nutr Biochem. 2015;26(2):99-111.

  14. Ailhaud G et al. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res. 2006;45(3):203-36.

  15. Willers SM et al. BMI Development of Normal Weight and Overweight Children in the PIAMA Study. PLoS One. 2012;7(6):e39517.

  16. Ailhaud G et.al. An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?. Br J Nutr. 2008;100(3):461-70.

  17. Calder PC. n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids, 2003. 38(4): p. 343-52.

  18. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 2006. 83(6): p. S1505-1519.

  19. Moon RJ, Harvey NC et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab. 2013 Jan;98(1):299-307.

  20. Carlson SJ et al. The role of the ω-3 fatty acid DHA in the human life cycle. JPEN. 2013;37(1):15-22.

  21. Tai EK, Wang XB, Chen ZY. An update on adding docosahexaenoic acid (DHA) and arachidonic acid (AA) to baby formula. Food Funct. 2013 ;4(12):1767-75.

  22. Li J et al. Intakes of long-chain omega-3 (n23) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr 2013;97:1816.

  23. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  24. Qawasmi A et al. Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics. 2013;131(1):262-72.

  25. Willatts P et al. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet, 1998. 352(9129): 688-91.

  26. Willatts P et al. Effects of long-chain PUFA supplementation in infant formula on cognitive function in later childhood. Am J Clin Nutr. 2013;98(2):536S-42S.

  27. Bouwstra H et al. Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am J Clin Nutr, 2003. 78(2): 3138.

  28. Stahl B et al. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem. 1994;223(2):218-26.

  29. Moro G et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291-5.

  30. Moro GE et al. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatr Suppl. 2005;94(449):27-30.

  31. Boehm G et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004; 38: S76-9.

  32. Vandenplas Y et al. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br J Nutr. 2015;113(9):1339-44.

  33. Wopereis H et al. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol. 2014;25:428–438.

  34. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238–225.

  35. Chistiakov DA et al. Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance. Front Microbiol. 2015; 13(5):781-9.

  36. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313-23.

  37. Bar-Yoseph F et al. Review of sn-2 palmitate oil implications for infant health. Prostaglandins Leukot Essent Fatty Acids. 2013;89(4):139-43.

  38. Havlicekova Z et al. Beta-palmitate - a natural component of human milk in supplemental milk formulas. Nutr J. 2016;15(1):28.

  39. Litmanovitz I et al. Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial. BMC Pediatr. 2014;14:152.

  40. Yao M et al. Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity. J Pediatr Gastroenterol Nutr. 2014 ;59(4):440-8.

  41. Nowacki J et al. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial. Nutr J. 2014;13:105.

  42. Koletzko B et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr. 2009; 89: 1836–45.

  43. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  44. Michaelsen KF et al. Protein needs early in life and long term health. Am J Clin Nutri 2014;99 (suppl):718S -22S.

  45. Patro Golab B et al. Protein Concentration on milk formula, growth, and later risk of obesity: a systematic Review. J Nutr 2016; 1-14.

  46. Putet G et al. Effect of dietary protein on plasma isulin-like growth factor -1, growth, and body composition in healthy term infants: a randomized, doubleblind, controlled trial (Early Protein and Obesity in Childhood (EPOCH ) study. Br J NUtr 2015.

  47. Weber M et al. Lower protein content in formula reduce BMI and obesity risk at school age: follow – up of a randomized trial. AM J CLin Nutr 2014;99:1041-51.

 

Aptamil Premium:

 

  1. SBP. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  2. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011; 52:238–225.

  3. Oozeer R et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr. 2013;98(2):561S-71S.

  4. Moro G et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291-5.

  5. Knol J et al. Colon microflora in infants fed formula with galacto- and fructo- oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40(1):36-42.

  6. Scholtens PA et al. Stool characteristics of infants receiving short-chain galacto- oligosaccharides and long-chain fructo-oligosaccharides: a review. World J Gastroenterol. 2014;20(37):13446-52.

  7. Ryan AS, Hay WW Jr. Challenges of infant nutrition research: a commentary. Nutr J. 2016 22;15:42.

  8. Comparativo de produtos de mesma categoria realizada em abril de 2020.

  9. Calder PC. n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids, 2003. 38(4): p. 343-52.

  10. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 2006. 83(6): p. S1505-1519.

  11. Carlson SJ et al. The role of the ω-3 fatty acid DHA in the human life cycle. JPEN. 2013;37(1):15-22.

  12. Tai EK, Wang XB, Chen ZY. An update on adding docosahexaenoic acid (DHA) and arachidonic acid (AA) to baby formula. Food Funct. 2013 ;4(12):1767- 75.

  13. Li J et al. Intakes of long-chain omega-3 (n23) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr 2013;97:181–6.

  14. Qawasmi A et al. Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics. 2013;131(1):262-72.

  15. Stahl B et al. Oligosaccharides from human milk as revealed by matrix- assisted laser desorption/ionization mass spectrometry. Anal Biochem. 1994;223(2):218-26.

  16. Moro G et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291-5.

  17. Moro GE et al. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatr Suppl. 2005;94(449):27-30.

  18. Boehm G et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004; 38: S76-9.

  19. Vandenplas Y et al. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br J Nutr. 2015;113(9):1339-44.

  20. Wopereis H et al. The first thousand days - intestinal microbiology of early life: establishing a symbiosis. Pediatr Allergy Immunol. 2014;25:428–438.

  21. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238–225.

  22. Chistiakov DA et al. Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance. Front Microbiol. 2015; 13(5):781-9.

  23. Koletzko B et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr. 2009; 89: 1836–45.

  24. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  25. Michaelsen KF et al. Protein needs early in life and long term health. Am J ClinNutri 2014;99 ( suppl):718S -22S.

  26. Patro Golab B et al. Protein Concentration on milk formula, growth, and later risk of obesity: a systematic Review. J Nutr 2016; 1-14.

  27. Putet G et al. Effect of dietary protein on plasma isulin-like growth factor - 1, growth, and body composition in healthy term infants: a randomized, doubleblind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study. Br J NUtr 2015.

  28. Weber M et al. Lower protein content in formula reduce BMI and obesity risk at school age: follow – up of a randomized trial. AM J CLin Nutr 2014;99:1041-51.

 

Milupa:

 

  1. SBP. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  2. Resolução da Diretoria Colegiada – RDC nº 43, de 19 de setembro de 2011.

  3. Resolução da Diretoria Colegiada – RDC nº 44, de 19 de setembro de 2011.

 

Linha Milnutri:

 

  1. Liu L et al. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res. 2014;55(3):531-9.

  2. Wijendran V et al. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr.Res.2002;51(3):265-72.

  3. Graf et al. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2010; 83 (2): 89-96.

  4. Kabaran S, Besler HT. Do fatty acids affect fetal programming? J Health Popul Nutr. 2015;33:14.

  5. Innis SM. Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr. 2011;7 Suppl 2:112-23.

  6. Pedersen L et al. Polyunsaturated fatty acid content of mother’s milk is associated with childhood body composition. Pediatr Res. 2012;72(6):631-6.

  7. Mennitti LV et al. Type of fatty acids in maternal diets during pregnancy and/or lactation and metabolic consequences of the offspring. J Nutr Biochem. 2015;26(2):99- 111.

  8. Ailhaud G et al. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res. 2006;45(3):203-36.

  9. Willers SM et al. BMI Development of Normal Weight and Overweight Children in the PIAMA Study. PLoS One. 2012;7(6):e39517.

  10. Ailhaud G et.al. An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br J Nutr.2008;100(3):461-70.

  11. Calder PC. n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids, 2003. 38(4): p. 343-52.

  12. Calder PC. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr, 2006. 83(6): p. S1505-1519.

  13. Moon RJ, Harvey NC et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab. 2013 Jan;98(1):299-307.

  14. Scholtens S et al. Breastfeeding, weight gain in infancy, and overweight at seven years of age: the prevention and incidence of asthma and mite allergy birth cohort study. Am J Epidemiol. 2007;165(8):919- 26.

  15. Bouwstra H et al. Long-chain polyunsaturated fatty acids have a positive effect on the quality of general movements of healthy term infants. Am J Clin Nutr, 2003. 78(2): 313- 8.

  16. Willatts P et al. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet, 1998. 352(9129): 688-91.

  17. Tai EK, Wang XB, Chen ZY. An update on adding docosahexaenoic acid (DHA) and arachidonic acid (AA) to baby formula. Food Funct. 2013 ;4(12):1767-75.

  18. Qawasmi A et al. Meta-analysis of LCPUFA supplementation of infant formula and visual acuity. Pediatrics. 2013;131(1):262-72.

  19. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-1.

  20. FAO. Fats and Fatty Acids in Human Nutrition: S. Karger AG; 2010.

  21. SNE health claims positively assessed by EFSA, 2014.

  22. Mello CS, Barros KV, Morais MB. Alimentação do lactente e do pré-escolar brasileiro: revisão da literatura. J. Pediatr. 2016; 92 (5): 451-463.

  23. Estudo Nutriplanet, Danone Early Life Nutrition. Revisão sistemática da literatura científica sobre o contexto alimentar e nutricional de gestantes, lactantes, lactentes e primeira infância, 2012.

  24. Carvalho CA, et al. Consumo Alimentar e adequação nutricional em crianças brasileiras: revisão sistemática. Ver. Paul. pediatr. 2015 33 (2): 211-221.

  25. Chatchatee P, Lee WS, Carrilho E. Effects of Growing-Up Milk Supplemented With Prebiotics and LCPUFAs on Infections in Young Children. JPGN. 2014;58:428–37.

  26. Suthutvoravut U, et al. Composition of Follow-Up Formula for Young Children Aged 12- 36 Months: Recommendations of an International Expert Group Coordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Ann NutrMetab. 2015;67(2):119-32.

  27. Iron Deficiency Anaemia. Assessment, Prevention and Control. WHO, 2001.

  28. Vieux F, et al. Role of Young Child Formulae and Supplements to Ensure Nutritional Adequacy in U.K Young children. Nutrients MPDI,2016.

  29. Eussen SRBM, et al. Theoretical Impact of Replacing Whole Cow’s Milk by Young-Child Formula on Nutrient Intakes of UK Young Children: Results of a Simulation Study. Annals of Nutrition and Metabolism, 2015.

  30. Pedraza DF. Micronutrientes no crescimento e desenvolvimento infantil. Ver. Bras. Crescimento desenvolv. Hum 2011; 21 (1), 156- 171.

  31. Comparativo de produtos de mesma categoria realizada em abril de 2020.

 

Linha Pre:

 

  1. Koletzko B, Poindexter B, Uauy R. Nutritional Care of Preterm Infants: Scientific Basis and Practical Guidelines. World Rev Nutr Diet. 2014; 110: 1–314.

  2. Agostoni C et al. Enteral Nutrient Supply for Preterm Infants: Commentary from the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 2010; 50 (1): 85-91.

  3. Lapillonne et al. Nutritional Recommendations for the Late-Preterm Infant and the Preterm Infant after Hospital Discharge. J Pediatr 2013;162:S90-100.

  4. Teller IC et al. Post-discharge formula feeding in preterm infants: A systematic review mapping evidence about the role of macronutrient enrichment. Clinical Nutrition 35 (2016) 791e801.

  5. Aggett PJ et al. Feeding Preterm Infants After Hospital Discharge: A Commentary by the ESPGHAN Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition. 2006; 42(5):596-602.

  6. Alberta Health Services. Nutrition Guideline Healthy Infants and Young Children Post- discharge Preterm Formula (PDPF). 2014, p 3.2.1- 3.2.5.

  7. Liu L et al. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res. 2014;55(3):531-9.

  8. Wijendran V et al. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res. 2002;51(3):265-72.

  9. Graf et al. Age dependent incorporation of 14C-DHA into rat brain and body tissues after dosing various 14C-DHA-esters. Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 2010;83(2):89-96.

  10. Knol J et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatrica, 2005;94(Suppl 449):31-33.

  11. Bruzzese E et al. Early administration of GOS/FOS prevents intestinal and respiratory infections in infants. J Pediatr Gastroenterol Nutr. 2006;42(5):E95.

  12. Westerbeek EAM et al. Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010;91:679-86.

  13. Westerbeek EAM et al. Design of a randomized controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study. BMC Pedriatrics 2008, 8:46.

  14. Boehm G et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts on faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002;86(3):F178-81.

  15. Comparativo de rótulo de mesma categoria realizada em abril de 2020.

  16. Roy CC et al. Correction of the malabsorption of the preterm infant with a medium- chain triglyceride formula. J Pediatr. 1975;86(3):446-50.

 

Aptamil Active:

 

  1. Schmelzle H et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003, 36:343-51.

  2. Bongers ME et al. The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial. Nutr J 2007;6:8.

  3. Savino F et al. “Minor” feeding problems during the first months of life: effect of a partially hydrolyzed milk formula containing fructo- and galacto-oligosaccharides. Acta Paediatr Suppl 2003, 91:86-90.

  4. Savino F et al. Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr 2006, 60:1304- 10.

  5. Savino F et al. Advances in the management of digestive problems during the first months of life. Acta Paediatr Suppl 2005, 94:120.

  6. Rigo J, Pieltain C, Studzinski F, Knol J, Bindels JG. Clinical evaluation in term infants of a new formula based on prebiotics, beta-palmitate and hydrolysed proteins. Pediatr Gastroenterol. Nutr 2001;32:402–7.

  7. Rinne MM, Gueimonde M, Kalliomäki M, Hoppu U, Salminen SJ, Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol 2005;43:59-65.

 

Aptamil AR:

 

  1. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  2. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  3. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  4. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  5. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  6. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  7. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  8. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

 

Aptamil SL:

 

  1. Heyman MB; Committee on Nutrition. Lactose intolerance in infants, children and adolescents. Pediatrics. 2006; 118(3): 1279-86.

  2. MacGillivray S et al. Lactose avoidance for young children with acute diarrhea.Cochrane Database Syst Rev, 2013;10(-):CD005433.

  3. Simakachorn N et al. Randomized, double-blind clinical trial of a lactose-free and a lactose-containing formula in dietary management of acute childhood diarrhea. J Med Assoc Thai. 2004 Jun;87(6):641-9.

  4. Comparativo dos produtos da mesma categoria no mercado realizada em abril de 2020.

 

Aptamil HA:

 

  1. Moro G et.al. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child, 2006. 91(10): p. 814-9. 10.

  2. Arslanoglu S et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr, 2008. 138(6): p. 1091-5.

  3. Arslanoglu S et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents, 2012. 26(3 Suppl): p. 49-59.

  4. Wopereis H et al. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development. J Allergy Clin Immunol. 2017. pii: S0091- 6749(17)31343-X.

  5. Boyle RJ et al. Prebiotic supplemented partially hydrolyzed cow’s milk formula for the prevention of eczema in high risk infants: a randomized controlled trial. Allergy 2016;71:701-10.

  6. Tang M et al. Hypo-antigenic and immune modulatory properties of a partially hydrolyzed cow’s milk formula supplemented with prebiotic oligosaccharides. EAACI, 2014 (Abstract number 1929).

  7. van Esch BC et al. Oral tolerance induction by partially hydrolyzed whey protein in mice is associated with enhanced numbers of Foxp3(+) regulatory T-cells in the mesenteric lymph nodes. Pediatr Allergy Immunol 2011;22:820–826.

  8. van Esch et al. Running title: Dietary intervention with non-digestible oligosaccharides enhances CD103+ DC and reduced allergic symtoms and IgE in partial whey hydrolysed tolerized mice. 2014, Submitted.

  9. Boyle RJ et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta-analysis. BMJ. 2016;352:i974.

  10. Cuello-Garcia CA et al. World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): prebiotics. World Allergy Organ J. 2016;9:10.

  11. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em novembro de 2018.

 

Neocate LCP:

 

  1. Dupont et al. JPGN 1999; 28:589.

  2. De Bossieu D., Dupont C.J Pediatr 2000 Jan; 136(1): 119-2.

  3. Sampson HA et al. Pediatrics 1992; 90(3): 463- 465.

  4. De Boissieu D., Dupont C. J Pediatr 2002; 141: 271-3 18 19.

  5. Niggemann B et al. Pediatr Allergy Immunol 2001; 12: 78-82 20.

  6. Vanderhoof JA et al.J Pediatr 1997; 131: 741-744 21. 7. Hill DJ and col. JACI 1995 Sep; 96(3): 386- 94 22.

  7. Kelly KJ et al. Gastroenterology 1995; 109: 1503-1512 23.

  8. Markowitz et al. Am J Gastroenterol 2003 Apr; 98(4): 777- 82 24.

  9. Hill DJ and col. J Pediatr 1999 Jul; 135(1): 118-21.

  10. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 - Parte 1 e Parte 2 - Diagnóstico, tratamento e prevenção. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunologia. Arq Asma Alerg Imunol. 2018;2(1):39-82.

  11. Morais MB et al. Amino acid formula as a new strategy for diagnosing cow´s milk allergy in infants: is it cost-effective? J Med Econ. 2016 May 6:1-21.

  12. Vandenplas Y, Bueton M, Dupont C, et al. Guidelines for the diagnosis and.

  13. management of cow’s milk protein allergy in infants. Arch Dis Child 2007; 92: 902-8.

  14. Meyer R, Groetch M, Venter C. When Should Infants with Cow’s Milk Protein Allergy Use an Amino Acid Formula? A Practical Guide. J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):383-399.

  15. Venter C, Brown T, Meyer R, et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017 Aug 23;7:26.

  16. Luyt D, Ball H, Makwana N, et al. BSACI guideline for the diagnosis and management of cow’s milk allergy. Clin Exp Allergy 2014;44:642-72.

  17. Fiocchi A, Brozek J, Schünemann H, et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. World Allergy Organ J 2010; 3 (4): 57-161.

 

Pregomin:

 

  1. Koletzko S et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55 (2):221-9.

  2. Muraro A et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-25.

  3. Solé D et al. Guia prático de diagnóstico e tratamento da alergia às proteínas do leite de vaca mediada pela imunoglobulina E. Rev Bras Alerg Imunopatol. 2012;35(6):203-33. 4. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82.

  4. Fiocchi A et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol. 2010;21 Suppl 21:1-125.

  5. Venter C et al. Diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: a UK primary care practical guide. Clin Transl Allergy.2013;3(1):23.

  6. Venter C et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017;7:26.

  7. Allen KJ et al. Management of cow’s milk protein allergy in infants and young children: an expert panel perspective. J Paediatr Child Health. 2009;45(9):481-6.

  8. De Greef E et al. Diagnosis and management of cow’s milk protein allergy in infants. World J Pediatr. 2012;8(1):19-24.

  9. Orsi M et al. Alergia a la proteína de la leche de vaca: Propuesta de Guía para el manejo de los niños com alergia a la proteína de la leche de vaca. Arch. argent. pediatr. 2009; 107( 5 ): 459-467.

  10. Verwimp JJ et al. Symptomatology and growth in infants with cow’s milk protein intolerance using two different whey-protein hydrolysate-based formulas in a Primary Health Care setting. Eur J Clin Nutr. 1995 Sep;49 Suppl 1:S39-48.

  11. Estudo observacional, prospectivo aberto e multicêntrico de vigilância pós- comercialização sobre aceitabilidade e tolerabilidade de uma fórmula infantil extensamente hidrolisada. Brasil, 2016: dados preliminares.

  12. Estudo sobre palatabilidade e percepção sensorial de mães brasileiras quanto às diferentes fórmulas para tratamento da alergia ao leite de vaca. Brasil, 2016: dados preliminares.

 

Aptamil Pepti:

 

  1. Koletzko S et al. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr. 2012;55 (2):221-9.

  2. Muraro A et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-25.

  3. Solé D et al. Guia prático de diagnóstico e tratamento da alergia às proteínas do leite de vaca mediada pela imunoglobulina E. Rev Bras Alerg Imunopatol. 2012;35(6):203-33.

  4. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82.

  5. Fiocchi A et al. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol. 2010;21Suppl 21:1-125.

  6. Venter C et al. Diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: a UK primary care practical guide. Clin Transl Allergy. 2013;3(1):23.

  7. Venter C et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017;7:26.

  8. Allen KJ et al. Management of cow’s milk protein allergy in infants and young children: an expert panel perspective. J Paediatr Child Health. 2009;45(9):481-6.

  9. De Greef E et al. Diagnosis and management of cow’s milk protein allergy in infants. World J Pediatr. 2012;8(1):19-24.

  10. Orsi M et al. Alergia a la prote na de la leche de vaca: Propuesta de Guía para el manejo de los niños con alergia a la proteína de la leche de vaca. Arch. argent.pediatr. 2009; 107( 5 ): 459-467.

  11. Giampietro PG. et al. Hypoallergenicity of an extensively hydrolyzed whey formula. Pediatr Allergy Immunol 2001. 12 (2): 83-86.

  12. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em Novembro de 2018.

  13. Estudo observacional, prospectivo aberto e multicêntrico de vigilância pós- comercialização sobre aceitabilidade e tolerabilidade de uma fórmula infantil extensamente hidrolisada. Brasil, 2016: dados preliminares.

  14. Estudo sobre palatabilidade e percepção sensorial de mães brasileiras quanto às diferentes fórmulas para tratamento da alergia ao leite de vaca. Brasil, 2016: dados preliminares.

 

Aptamil Soja 2:

 

  1. Agostoni C et al. Soy protein infant formulae and follow-on formulae: A commentary by the ESPGHAN Committee on Nutrition. J Ped Gast Nutr 2006: 42:352- 61.

  2. Bhatia J, Greer F. American Academy of Pediatrics Committee on Nutrition: Use of soy protein-based formulas in infant feeding. Pediatrics. 2008;121(5):1062-8.

  3. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82.

 

Neo Spoon:

 

  1. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 - Parte 1 e Parte 2 - Diagnóstico, tratamento e prevenção. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunologia. Arq Asma Alerg Imunol. 2018;2(1):39-82.

  2. Vieira MC, Morais MB, Spolidoro JVN, Toporovski MS, Cardoso AL, Araujo GTB et al. A survey on clinical presentation and nutritional status of infants with suspected cow’s milk allergy. BMC Pediatr. 2010:10:1–7. 24.

  3. Meyer R et al. Malnutrition in children with food allergies in the UK. Journal of Human Nutrition and Dietetics. 2014; 27,227–235.

  4. Meyer R et al. Feeding difficulties in children with food protein- induced gastrointestinal allergies. Journal of Gastroenterology and Hepatology 29 (2014) 1764–1769.

  5. Medeiros LCS et al. Ingestão de nutrientes e estado nutricional de crianças em dieta isenta de leite de vaca e derivados. J. Pediatr. (Rio J.) vol.80 no.5 Porto Alegre, 2004.

  6. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  7. Isolauri et al. Efficacy and safety of hydrolyzed cow milk and amino-acid derived formulas in infants with cow milk allergy. J Pediatrics 1995; 127: 550-57.

  8. Canani RB et al. Amino Acid-based Formula in Cow’s Milk Allergy: Long-term Effects on Body Growth and Protein Metabolism. A Randomized Trial. J Pediatr Gastroenterol Nutr. 2016 Jul 20.

  9. Vanderhoof J et al. Evaluation of an Amino Acid Based Formula in Infants Not Responding to Extensively Hydrolyzed Protein Formula. JPGN Volume 63, Number 5, November 2016.

  10. Manual do lanche saudável/ Virginia Resende Silva Weffort... [et al.]. – São Paulo: Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia, 2011.

 

Neo Advance:

 

  1. Braegger C et al. Practical Approach to Paediatric Enteral Nutrition: A comment by the Espghan Committee on Nutrition. JPGN 2010; 51(1): 110-122.

  2. Axerold D et al. Pediatric Enteral Nutrition. Journal of parenteral and enteral nutrition. 2006; 30(1).

  3. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 - Parte 1 e Parte 2 - Diagnóstico, tratamento e prevenção. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunologia. Arq Asma Alerg Imunol. 2018;2(1):39-82.

  4. Manual de orientação para a alimentação do lactente, do pré-escolar, do escolar, do adolescente e na escola. Sociedade Brasileira de Pediatria. Departamento de Nutrologia, 3ª edição. Rio de Janeiro. RJ: SBP, 2012, 148p. Resolução RDC nª269, de 22/09/05.

  5. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  6. IOM (Institute of Medicine). Dietary Reference Intakes for Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino Acids (2002/2005).

 

Neoforte:

 

  1. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 – Parte 1 e Parte 2 – Diagnóstico, tratamento e prevenção. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunologia. Arq Asma Alerg Imunol. 2018;2(1):39-82.

  2. Manual de orientação para a alimentação do lactente, do pré-escolar, do escolar, do adolescente e na escola. Sociedade Brasileira de Pediatria. Departamento de Nutrologia, 3ª edição. Rio de Janeiro. RJ: SBP, 2012, 148p. Resolução RDC nª269, de 22/09/05.

  3. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  4. IOM (Institute of Medicine). Dietary Reference Intakes for Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino Acids (2002/2005).

  5. Maslin K et al. Fussy eating and feeding difficulties in infants and toddlers consuming a cows’ milk exclusion diet. Pediatric Allergy and Immunology 26 (2015) 503–508.

  6. Mukaida K et al. The Effect of Past Food Avoidance Due to Allergic Symptoms on the Growth of Children at School AgeAllergology International. 2010;59:369-374.

  7. Medeiros LCS et al. Ingestão de nutrientes e estado nutricional de crianças em dieta isenta de leite de vaca e derivados. J. Pediatr. (Rio J.) vol.80 no.5 Porto Alegre, 2004.

  8. Meyer R. Nutritional Disorders resulting from Food Allergy in Children. Pediatric allergy and immunology. Pediatric Allergy and Immunology. Doi: 10.1111/pai.12960.

  9. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em Novembro de 2018.

 

Milnutri Soja:

 

  1. Solé D et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82.

  2. Agostoni C et al. Soy protein infant formulae and follow-on formulae: A commentary by the ESPGHAN Committee on Nutrition. J Ped Gast Nutr 2006: 42:352- 61.

  3. Bhatia J, Greer F. American Academy of Pediatrics Committee on Nutrition: Use of soy protein-based formulas in infant feeding. Pediatrics. 2008;121(5):1062-8.

  4. Messina M et al. Health impact of childhood and adolescent soy consumption. Nutr Rev. 2017;75(7):500-515.

 

Ketocal:

 

  1. Sampaio LPB, Takakura C, Manreza, MLG. The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. NeuroPsiquiatr. 2017;75(4):234-237.

  2. Coppola G, Verrotti A, Ammendola E, Operto FF, Corte RD, Signoriello G et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol. 2010; 14(3):229–234.

  3. Weijenberg A, van Rijn M, Callenbach PMC, de Koning TJ, Brouwer OF. Ketogenic Diet in Refractory Childhood Epilepsy: Starting With a Liquid Formulation in an Outpatient Setting. Child Neurol Open. 2018;5:2329048X18779497.

  4. Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia. 2017;58(2):e36-e39.

  5. Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26(2):147-51.

  6. Ashrafi MR, Hosseini SA, Zamani GR, Mohammadi M, Tavassoli A, Badv RS et al. The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula-based powder. Acta Neurol Belg. 2017;117(1):175-182.

  7. Uldall P et al. Ketogenic diet for infants is possible with Ketocal. Epilepsia. 2006;47(S3):176.

  8. Rubenstein JE. Use of the ketogenic diet in neonates and infants. Epilepsia. 2008;49(Suppl 8):30-2.

  9. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008;23(7):758-61.

  10. Kossoff EH et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 Jun; 3(2): 175–192.

  11. Sampaio LPB. ABC da dieta cetogênica para epilepsia refratária. Rio de Janeiro: Editora DOC Content, 2018. 1a edição, 220 p.

 

Infatrini:

 

  1. Clarke SE, Evans S, MacDonald A, Davies P, Booth IW. Randomized comparison of a nutrient‐dense formula with an energy‐supplemented formula for infants with faltering growth. J Hum Nutr Diet. 2007;20(4):329-339.

  2. Falcão MC, Udsen N, Zamberlan P, Ceccon MER. Uso de dieta hiperproteica e hipercalórica em lactente com cardiopatia congênita grave e falha de crescimento. Rev Bras Nutr Clin 2009;24(2):125-30.

  3. Joosten K, Meyer R. Nutritional screening and guidelines for managing the child with faltering growth. EJCN. 2010;64:S23-S24.

  4. Pencharz PB. Protein and energy requirements for optimal catch-up growth. EJCN.2010;64: S5-7.

  5. FAO/WHO/UNU. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. WHO technical report series. 2007;935.p.187.

  6. ASPEN Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. Section XII: administration of specialized nutrition support – Issues unique to pediatrics. JPEN. 2002;26(1 Suppl).

  7. Comparativo de rotulagem de produtos da mesma categoria no mercado, realizado em Maio de 2020.

 

Milnutri Complete:

 

  1. Kerzner B, Milano K, MacLean WC Jr, Berall G, Stuart S, Chatoor I. A Practical Approach to Classifying and Managing Feeding Difficulties. Pediatrics. 2015; 135(2):344-53.

  2. Fisberg M, Maximino P. Dificuldades Alimentares. In: Nogueira-de-Almeida CA, Mello ED. Nutrologia Pediátrica: Prática Baseada em Evidências. Barueri: Manole; 2016. 117-25.

  3. IOM - Institute of Medicine. Dietary Reference Intakes - The Essential Guide to Nutrient Requirements. Washington: The National Academies Press; 2006. 69-413.

  4. FAO – Food and Agriculture Organization of United Nations. Fats and fatty acids in human nutrition: report of an expert consulation. Geneva: Food and Nutrition Paper; 2010. 91.

  5. Comparativo de rotulagem de produtos da mesma categoria no mercado, realizado em Maio de 2020.

  6. Scholtens PAMJ, Goosens DAM, Staiano A. Stool characteristics of infants receiving short- chain galacto-oligossacharides and long-chain fructo-oligossacharides: A review. World J Gastroenterol. 2004;20(37):13446-13452.

  7. Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K et al. Colon Microflora in Infants Fed Formula with Galacto- and Fructo-Oligosaccharides: More Like Breast-Fed Infants. JPGN. 2005;40:36-42.

  8. Giuntini EB, Menezes EW. Fibra Alimentar: Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 18. São Paulo, 2011.

 

Fortini:

 

  1. Giugliani ER, Victoria CG. Complementary Feeding. J Pediatr (Rio J) 2000;76(Supl.3):S253- S62.

  2. SBP - Sociedade Brasileira de Pediatria. Manual de orientação do departamento de nutrologia. Departamento Científico de Nutrologia Sociedade Brasileira de Pediatria. 2012. p 81.

  3. Shaw V, Lawson M. Clinical Paediatric Dietetics. 2nd edition. London: Blackwell Science; 2011.

  4. Comparativo de rotulagem de produtos da mesma categoria no mercado, realizado em Maio de 2020.

 

Fortini MF:

 

  1. Kasese-Hara M, Wright C, Drewett R. 2002; 43; 449-56.

  2. ASPEN Board of Directors. 2002; 26 (1 Suppl).

  3. Giugliani ER, Victoria CG. Complementary Feeding. J Pediatr (Rio J) 2000;76(Supl.3):S253- S62.

  4. Shaw V, Lawson M. Clinical Paediatric Dietetics. 2nd edition. London: Blackwell Science; 2011.

  5. IOM – Institute of Medicine. 2006; p.69-413 6. FAO. 2010; p.91

  6. SBP. 2012; p.81.

  7. Comparativo de rotulagem de produtos da mesma categoria no mercado, realizado em Maio de 2020.

 

Aptamil AR – Referências para o VA de lançamento – ABRIL 2020:

 

  1. HCPTRACKER 2019.

  2. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  3. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  4. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  5. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  6. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  7. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  8. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e Docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.

  9. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  10. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  11. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  12. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69

  13. Relatório de uso interno Danone Nutricia – Acesso: Junho/2020.

  14. Comparativo de produtos de mesma categoria realizado em Junho de 2020.

 

Como garantir a segurança na terapia nutricional dos pacientes pediátricos? Referências:

 

  1. Comparativo de tabela de nutricional e rotulagem feito com produtos da mesma categoria, realizado em Março de 2020.

  2. Braegger C, Decsi T, Dias JA, Hartman C, Kolaček S, Koletzko B et al. Practical Approach to Paediatric Enteral Nutrition: A Comment by the ESPGHAN Committee on Nutrition. JPGN; 2010:51(1):110-122.

  3. ASPEN. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. J Parenter Enteral Nutr, 2017; 41:706-742.

  4. WHO – World Health Organization. Guideline: Sugars intake for adults and children. Genebra; 2015.

  5. Fidler Mis, N et al. Sugar in Infants, Children and Adolescents: A Position Paper of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2017; 65(6):681-696.

  6. American Academy of Pediatrics. Added sugar in kids' diets: How much is too much? 2019.

 

Material Promocional Alergia Alimentar – Ciclo 01 (JAN) – lâmina Portfólio Completo Referências:

 

  1. Solé, D. et al. Consenso Brasileiro sore Alergia Alimentar: 2018. Parte 1 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela SBP e ASBAI. Braz J Allergy Immunol. 2018; 2:7-38.

  2. Arslanoglu S, Moro GE, Boehm G, Wienz F, Stahl B, Bertino E. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents. 2012;26(3 Suppl):49-59.

  3. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early Dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138(6):1091-5.

  4. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotics oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91(10):814-9.

  5. Tang ML, Nauta A, Rijnierse A, Knippels LM, Hourihane JO, Chiang WC et al. Hypo-antigenic and immune modulatory properties of a partially hydrolyzed cow´s milk formula supplemented with prebiotic oligosaccharides. European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Congress, Publisher: WILEY- BLACKWELL, Pages: 310-310.

  6. Boyle RJ, Tang ML, Chiang WC, Chua MC, Ismail I, Nauta A et al. Prebiotic supplemented partially hydrolysed cow´s milk formula for the prevention of eczema in high risk infants: a randomized controlled trial. Allergy. 2016;71:701-10.

  7. Wopereis H, Sim K, Shaw A, Warner JO, Knol J, Kroll JS. Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development. J Allergy Clin Immunol. 2018;141(4):1334-1342.

  8. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em janeiro de 2019.

  9. Fiocchi A, Schünemann HJ, Brozek J, Restani P, Beyer K, Troncone R et al. Diagnosis and Rationale for Action against Cow´s Milk Allergy (DRACMA) Guidelines. J Allergy Clin Immunol. 2010;126(6):1119-28.

  10. Vandenplas Y, Koletzko S, Isolauri E, Hill D, Oranje AP, Brueton M et al. Guidelines for the diagnosis and management of cow´s milk protein allergy in infants. Arch Dis Child. 2007;92(10):902-8Koletzko S.

  11. Niggemann B, Arato A, Dias JA, Heuschkel R, Husby S et al. Diagnostic approach and management of cow´s milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. JPGN. 2012;55(2):221-9.

 

Referências Aptamil Pepti:

 

  1. Solé, D. et al. Consenso Brasileiro sore Alergia Alimentar: 2018. Parte 1 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela SBP e ASBAI. Braz J Allergy Immunol. 2018; 2:7-38.

  2. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  3. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  4. IOM (Institute of Medicine). Dietary Reference Intakes for Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino Acids (2002/2005).

  5. Resolução RDC nº 43 e 44, de 21 de setembro de 2011. Regulamento técnico para fórmulas infantis. ANVISA - Agência Nacional de Vigilância Sanitária, de 21 de setembro de 2011.

  6. Willatts P, Forsyth JS. The role of long chain polyunsaturated fatty acids in infant cognitive development. Prostaglandins Leukot Essent Fatty Acids 2000;63:95-100.

  7. Maslin K, Fox A, Chambault M, Meyer R. Palatability of hypoallergenic formulas for cow´s milk allergy and healthcare professional recommendation. Pediatr Allergy Immunol. 2018;29(8):857-62.

  8. Estudo observacional, prospectivo, aberto e multicêntrico de vigilância pós- comercialização sobre aceitabilidade e tolerabilidade de uma fórmula infantil extensamente hidrolisada. Brasil. 2016: dados preliminares.

  9. Estudo sobre palatabilidade e percepção sensorial de mães brasileiras quanto às diferentes fórmulas para tratamento da alergia ao leite de vaca. Brasil, 2016: dados preliminares.

  10. Feferbaum R, Falcao MC, eds. Nutricao do recém nascido. Sao Paulo: Editora Atheneu, 2003.

  11. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G. Dosage related bifi dogenic eff ects of galactoand fructo-oligosaccharides in formula-fed term infants. J Pediatr gastroenterol Nutr 2002;34:291-5.

  12. Boehm G et. al. Prebiotics in Infant Formulas Immune Modulators during infancy. Nutrafoods 2005;4(2/3):51-7.

  13. Knol J et. al. Increase of faecal bifi dobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula- fed preterm infants. Acta Paediatr Suppl 2005; 94(449):31-3.

  14. Functional food science and gastrointestinal physiology and function. Salminen S et al. Br J Nutr 1998;80 (Suppl 1):S147-71.

  15. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em janeiro de 2019.

 

Referencias Material de Neo Advance:

 

  1. Solé, D. et al. Consenso Brasileiro sore Alergia Alimentar: 2018. Parte 1 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela SBP e ASBAI. Braz J Allergy Immunol. 2018; 2:7-38.

  2. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  3. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  4. IOM (Institute of Medicine). Dietary Reference Intakes for Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino Acids (2002/2005).

  5. Maslin K, Dean T, Arshd SH, Venter C. Fussy eating and feeding difficulties in infants and toddlers consuming a cow´s milk exclusion diet. Pediatr Allergy Immunol. 2015;26(6):503- 8.

  6. Meyer R, De Koker C, Dziubak R, Venter C, Dominguez-Ortega G, Cutts R et al. Malnutrition in children with food allergies in the UK. J Hum Nutr Diet. 2014;27(3):227-35.

  7. Kasese-Hara M, Wright C, Drewett R. Energy compensation in children who fail to thrive. J Child Psychol Psychiatry. 2002;43:449-56.

  8. Giugliani ER, Victoria CG. Complementary Feeding. J Pediatr (Rio J) 2000;76(Supl.3):S253-S62.

  9. Comparativo de tabela nutricional de produtos da mesma categoria no mercado realizada em janeiro de 2019.

  10. Maslin K, Dean T, Arshd SH, Venter C. Fussy eating and feeding difficulties in infants and toddlers consuming a cow´s milk exclusion diet. Pediatr Allergy Immunol. 2015;26(6):503-8.

  11. Sinai T, Goldgberg MR, Nachshon L, Amitzur-Levy R, Yichie T, Katz Y et al. Reduced Final Height and Inadequate Nutritional Intake in Cow's Milk-Allergic Young Adults. J Allergy Clin Immunol Pract. 2019 Feb;7(2):509-515.

  12. Singhal S; Baker R D; Baker S S. A Comparison of the Nutritional Value of Cow’s Milk.

  13. and Nondairy Beverages. JPGN Volume 64, Number 5, May 2017.

  14. Skypala, IJ, McKenzie R. Nutritional Issues in Food Allergy. Clin Rev Allergy Immunol. 2019 Oct;57(2):166-178.

  15. Bragger C et al. Practical Approach to Paediatric Enteral Nutrition. A Comment by the ESPGHAN Committee on Nutrition. JPGN 2010; 51: 110–122.

  16. Van Waadenburg DA, Betue CT, Goudoever JB et al. Critically ill infants benefit from early administration of protein and energy enriched formulas: a randomized controlled trial. Clinical Nutrition, 2009; 28(3): 249-55.

* Doses de 200ml considerando as recomendações para crianças de 4 a 6 anos, segundo a SBP

 

Referências Material Neocate LCP:

 

  1. Gupta RS et al. Food allergy knowledge, attitudes and beliefs: Focus groups of parents, physicians and the general public. BMC Pediatrics 2008, 8:36.

  2. Venter C et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017 Aug 23;7:26.

  3. Solé D, Silva LR, Cocco RR et al. Consenso Brasileiro sobre Alergia Alimentar: 2018 - Parte 1 e 2 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela Sociedade Brasileira de Pediatria e Associação Brasileira de Alergia e Imunologia. Braz J Allergy Immunol. 2018;2:7-38.

  4. Anagnostou K et al. The rapidly changing world of food allergy in children. Published online 2015 Mar 3. doi: 10.12703/P7-35. 6. Venter C et al. Better recognition, diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: iMAP-an international interpretation of the MAP (Milk Allergy in Primary Care) guideline. Clin Transl Allergy. 2017 Aug 23;7:26.

  5. Feuille E, Nowak-Węgrzyn A. Food Protein-Induced Enterocolitis Syndrome, Allergic Proctocolitis, and Enteropathy. Curr Allergy Asthma Rep Aug;15(8):50; 2015.

  6. Ferreira CT et al. Gastroesophaseal reflux disease: exaggerations, evidence and clinical practice. J Pediatr (Rio J). 2014;90(2):105-118.

  7. Dupont C et al. Nutritional management of cow’s milk allergy in children: An update. Arch Pediatr. 2018 Apr;25(3):236-243.

  8. Venter C et al. Diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy: a UK primary care practical guide. Clin Transl Allergy. 2013;3(1):23.

  9. Meyer R, Groetch M, Venter C. When should infants with cow´s milk protein allergy use an amino acid formula? A practical guide. J ALLERGY CLIN IMMUNOL PRACT MARCH/APRIL 2018.

  10. Mauro M B, Spolidoro J V, Vieira M C, Cardoso A, Clark O, Nishikawa A. Formula de Aminoácidos como uma nova estratégia para o diagnostico de alergia ao leite de vaca em lactentes: é custo-efetiva? Journal of Medical Economics. 2016; 19(12):1207-1214.

  11. Dupont C, Niggemann B, Binder C, Hadji S, Arvola T, Isolauri E. Early introduction of an amino acid-based vc protein hydrolysate formula in children with cow milk allergy: a randomized multicenter trial. JPGN. 1999;28(5):589.

  12. de Bossieu D, Dupont C. Time course of allergy to extensively hydrolyzed cow's milk proteins in infants. J Pediatr. 2000;136(1):119-2.

  13. Sampson HA, James JM, Bierhisel-Broadbent J. Safety of an amino acid-derived infant formula in children allergic to cow s milk. Pediatrics. 1992;90.

  14. Hill DJ, Cameron DJ, Francis DE, Gonzalez-Andaya AM, Hosking CS. Challenge confirmation of late-onset reactions to extensively hydrolyzed formulas in infants with multiple food protein intolerance. J Allergy Clin Immunol. 1995;96(3):386-94.

  15. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777-82.

  16. Hill DJ, Heine RG, Cameron DJ, Francis DE, Bines JE. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance. J Pediatr. 1999;135(1):118-21.

 

Referências Material Neo Spoon e Neoforte:

 

  1. Solé, D. et al. Consenso Brasileiro sore Alergia Alimentar: 2018. Parte 1 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela SBP e ASBAI. Braz J Allergy Immunol. 2018; 2:7- 38.

  2. Sociedade Brasileira de Pediatria – Departamento de Nutrologia Manual de Alimentação: orientações para alimentação do lactente ao adolescente, na escola, na gestante, na prevenção de doenças e segurança alimentar / Sociedade Brasileira de Pediatria. Departamento Científico de Nutrologia. – 4ª. ed. - São Paulo: SBP, 2018. 172 p.

  3. Resolução RDC nº 269, de 22 de setembro de 2005. Regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. ANVISA - Agência Nacional de Vigilância Sanitária, de 23 de setembro de 2005.

  4. IOM (Institute of Medicine). Dietary Reference Intakes for Energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino Acids (2002/2005).

  5. Maslin K, Dean T, Arshd SH, Venter C. Fussy eating and feeding difficulties in infants and toddlers consuming a cow´s milk exclusion diet. Pediatr Allergy Immunol. 2015;26(6):503-8.

  6. Meyer R, De Koker C, Dziubak R, Venter C, Dominguez-Ortega G, Cutts R et al. Malnutrition in children with food allergies in the UK. J Hum Nutr Diet. 2014;27(3):227-35.

  7. Kasese-Hara M, Wright C, Drewett R. Energy compensation in children who fail to thrive. J Child Psychol Psychiatry. 2002;43:449-56.

  8. Giugliani ER, Victoria CG. Complementary Feeding. J Pediatr (Rio J) 2000;76(Supl.3):S253-S62.

  9. Saad, SMI. Probióticos e prebióticos: o estado de arte. Rev. Bras. Cienc. Farm. vol.42 no.1 São Paulo Jan./Mar. 2006.

  10. Taylor CM, Wernimont SM, Northstone K, Emmett PM. Picky/fussy eating in children: Review of definitions, assessment, prevalence and dietary intakes. Appetite. 2015;95: 349-359.

  11. Carruth BR, Ziegler PJ, Gordon A, Barr SI. Prevalence of picky eaters among infants and toddlers and their caregivers’ decisions about offering a new food. J Am Diet Assoc. 2004;104:s57-64.

  12. Xue Y, Lee E, Ning K, Zheng Y, Ma D, Gao H et al. Prevalence of picky eating behavior in Chinese school-age children and associations with anthropometric parameters and intelligence quotient. A cross-sectional study. Appetite. 2015;91:248-255.

  13. Kerzner B, Milano K, MacLean WC Jr, Berall G, Stuart S, Chatoor I. A Practical Approach to Classifying and Managing Feeding Difficulties. Pediatrics. 2015; 135(2):344-53.

  14. Fisberg M, Maximino P. Dificuldades Alimentares. In: Nogueira-de-Almeida CA, Mello ED. Nutrologia Pediátrica: Prática Baseada em Evidências. Barueri: Manole; 2016. 117-25.

  15. Curva de crescimento adaptada de The WHO Child Growth Standards 2007. Disponível em: http://www.who.int/ childgrowth/standards/en/. Acesso em: 06/02/2019.

  16. Bragger C et al. Practical Approach to Paediatric Enteral Nutrition. A Comment by the ESPGHAN Committee on Nutrition. JPGN 2010; 51: 110–122.

  17. Van Waadenburg DA, Betue CT, Goudoever JB et al. Critically ill infants benefit from early administration of protein and energy enriched formulas: a randomized controlled trial. Clinical Nutrition, 2009; 28(3): 249-55.

 

Referências Neocate e Pregomin:

 

  1. Solé, D. et al. Consenso Brasileiro sore Alergia Alimentar: 2018. Parte 1 - Etiopatogenia, clínica e diagnóstico. Documento conjunto elaborado pela SBP e ASBAI. Braz J Allergy Immunol. 2018; 2:7-38.

  2. Dupont C, Niggemann B, Binder C, Hadji S, Arvola T, Isolauri E. Early introduction of an amino acid-based vc protein hydrolysate formula in children with cow milk allergy: a ramdomised multicenter trial. JPGN. 1999;28(5):589.

  3. de Bossieu D, Dupont C. Time course of allergy to extensively hydrolyzed cow's milk proteins in infants. J Pediatr. 2000;136(1):119-2.

  4. Sampson HA, James JM, Bierhisel-Broadbent J. Safety of an amino acid-derived infant formula in children allergic to cow s milk. Pediatrics. 1992;90.

  5. Fiocchi A; Schunemann H; Brozek J et al. Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol. 2010 Dec;126(6):1119-28.e12.

  6. de Bossieu D, Dupont C. Allergy to extensively hydrolyzed cow's milk proteins in infants: safety and duration of amino acid-based formula. J Pediatr. 2002;141(2):271-3.

  7. Niggemann B, Binder C, Dupont C, Hadji S, Arvola T, Isolauri E. Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol. 2001;12(2):78-82.

  8. Vanderhoof JA, Murray ND, Kaufman SS, Mack DR, Antonson DL, Corkins MR et al. Intolerance to protein hydrolysate infant formulas: an underrecognized cause of gastrointestinal symptoms in infants. J Pediatr. 1997;131:741-744.

  9. Hill DJ, Cameron DJ, Francis DE, Gonzalez-Andaya AM, Hosking CS. Challenge confirmation of late-onset reactions to extensively hydrolyzed formulas in infants with multiple food protein intolerance. J Allergy Clin Immunol. 1995;96(3):386-94.

  10. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109(5):1503- 12.

  11. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777-82.

  12. Hill DJ, Heine RG, Cameron DJ, Francis DE, Bines JE. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance. J Pediatr. 1999;135(1):118-21.

  13. Mauro M B, Spolidoro J V, Vieira M C, Cardoso A, Clark O, Nishikawa A. Formula de Aminoácidos como uma nova estratégia para o diagnostico de alergia ao leite de vaca em lactentes: é custo-efetiva? Journal of Medical Economics. 2016; 19(12):1207-1214.

  14. Willatts P, Forsyth JS. The role of long chain polyunsaturated fatty acids in infant cognitive development. Prostaglandins Leukot Essent Fatty Acids 2000;63:95-100.

  15. Estudo observacional, prospectivo, aberto e multicêntrico de vigilância pós-comercialização sobre aceitabilidade e tolerabilidade de uma fórmula infantil extensamente hidrolisada. Brasil. 2016: dados preliminares.

  16. Estudo sobre palatabilidade e percepção sensorial de mães brasileiras quanto às diferentes fórmulas para tratamento da alergia ao leite de vaca. Brasil, 2016: dados preliminares.

 

Referências Guia de Sintomas:

 

  1. Walsh, J. et al. Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations. British Journal of General Practice, August 2016.

  2. Solé, D et al. Consenso Brasileiro sobre alergia alimentar : 2018. Parte 1. Arq Asma Alerg Imunol. 2018;2(1):7-38.

  3. Vanderplas, Y. et al. Guidelines for de the diagnosis and management of cow´s milk protein allergy in infants. Arch Dis Child 2007;92:902–908.

  4. Benninga, M. et al. Childhood functional gastrointestinal disorders: neonate / toddler. Gastroenterology 2016;150:1443–1455.

  5. Koletzko, S; Heien, R.G. Non-IgE mediated cow’s milk allergy in EuroPrevall. Allergy 70 (2015) 1679–1680, 2015.

  6. Caubet, J.C. et al. Non IgE-mediated gastrointestinal food allergies in children. Pediatr Allergy Immunol 2017: 28: 6–17.

  7. ACAAI. Signs of allergies. Nausea and vomiting. Disponível em: https://acaai.org/allergies/allergy-symptoms/nausea- and-vomiting. Consultado em: 12.12.2019.

  8. Isolauri E., Sampson HA. JACI 2004 Feb: S154 15.

  9. Levy EI, Lemmens R, Vandeplas Y, Devreker T. Functional constipation in children: challenges and solutions. Pediatric Health, Medicine and Therapeutics. 2017;8:19-27.

  10. Koletzko S, Niggemann B, Arato A. et al. Diagnostic Approach and Management of Cow's-Milk Protein Allergy in Infants and Children: ESPGHAN GI Committee Practical Guidelines - J Pediatr Gastroenterol Nutr. 2012; 55(2): 221-9.

  11. Mehr S, Frith K, Campbell DE. Epidemiology of food protein-induced enterocolitis Syndrome. Allergy Clin Immunol 2014, 14 (3):208–216.

  12. Venter C, Groetch M.Nutritional management of food protein-induced enterocolitis syndrome. Allergy Clin Immunol 2014, 14:255–262.

  13. Cruz, C et al. Enterocolite induzida por proteínas alimentares. Rev Port Imunoalergologia vol.22 no.1 Lisboa mar. 2014.

  14. Camargo, L. et al. Allergic Proctocolits in infants: analysys of the evaluation of nutritional status. Arq Gastrenterol . V 53 n. 4 out/ dez 2016.

  15. Borges, W. Alergia Alimentar. Sociedade Brasileira de Pediatria. Acesso em 13 de dezembro de 2019.

  16. Delves, J. Angioedema. Manual para profissionais de saúde. Disponível em: https://www.msdmanuals.com/pt-br/profissional/imunologia-dist%C3%BArbiosal%C3%A9rgicos/dist%C3%BArbios-al%C3%A9rgicos,-autoimunes-e-outras-rea%C3%A7%C3%B5es-de-hipersensibilidade/angioedema. Acesso em 12 de dezembro 2019.

  17. Anafilaxia Definição. Disponível em: www.asbai.org.br. Acesso em 11 de dezembro de 2019.

  18. Tatachar P, Kumar S. Food-induced anaphylaxis and oral allergy syndrome. Pediatrics in review 2008;29:e23-e27.

  19. Bernd, L.A. et al. Anafilaxia: guia prático para o manejo. Rev. bras. alerg. imunopatol. – Vol. 29, Nº 6, 2006.

  20. Wassman A; werfel, T. Atopic eczema and food allergy. Food Allergy: Molecular Basis and Clinical Practice. Chem Immunol Allergy. Basel, Karger, 2015, vol 101, pp 181–190.

  21. National Eczema Association. Atopic dermatites. Disponível em: https://nationaleczema.org. Acesso em 13 de dezembro 2019.

  22. Chehade, M. et al. Food allergy and Eosinophilic Esophagitis: What Do We Do? ALLERGY CLIN IMMUNOL PRACT. JANUARY/FEBRUARY 2015.

  23. Chehade, M; Aceves, S. Food allergy and eosinophilic esophagitis. Current Opinion in Allergy and Clinical Immunology 2010, 10:231–237.

  24. Meyer R et al. Feeding difficulties in children with food protein-induced gastrointestinal allergies. Journal of Gastroenterology and Hepatology 29 (2014) 1764–1769.

  25. Vieira MC, Morais MB, Spolidoro JVN, Toporovski MS, Cardoso AL, Araujo GTB et al. A survey on clinical presentation and nutritional status of infants with suspected cow’s milk allergy. BMC Pediatr. 2010:10:1–7.

  26. Canani RB et al. The Effects of Dietary Counseling on Children with Food Allergy: A Prospective, Multicenter Intervention Study. Journal of the academy of nutrition and dietetics. Volume 114, Issue 9, September 2014, Pages 1432- 1439.

  27. Skypala IJ et al. Nutritional Issues in Food Allergy. Clin Rev Allergy Immunol. 2018 May 15. doi: 10.1007/s12016-018- 8688-x.

  28. The WHO Child Growth Standarts. Disponível em: https://www.who.int/childgrowth/standards/en/ Consultado em: 21 de janeiro de 2020.

  29. Vandenplas Y, Mukherjee R, Dupont C et al. Protocol for the validation of sensitivity and specificity of the Cow’s Milk related Symptom Score (CoMiSS) against open food challenge in a single blinded, prospective, multicentre trial in infants. BMJ Open 2018;8:e019968.

  30. Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, and van Tilburg M. Childhood Functional Gastrointestinal Disorders: Child/Adolescent. Gastroenterology 2016;150:1456–1468.

  31. Olden K W; Cheyala P. Functional nausea and vomiting. Nature Clinical Practice Gastroenterology & Hepatology volume 5, pages202–208(2008).

 

Referência: 36% dos pacientes diagnosticados com epilepsia não respondem aos farmacos anticonvulsivantes:

 

  1. Newton CR, Epilepsy in poor regions of the world The Lancet, Volume 380,Issue 9848;1193- 1201, 2012.

  2. Epilepsy Fact Sheet, World Health Organization, 2015.

  3. Engel J, What can we do for people with drugresitant epilepsy? The 2016 Warteberg Lecture. American Academy of Neurology.

  4. Sampaio LPB, Takakura C, Manreza, MLG. The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. NeuroPsiquiatr. 2017;75(4):234-237.

  5. Weijenberg A, van Rijn M, Callenbach PMC, de Koning TJ, Brouwer OF. Ketogenic Diet in Refractory Childhood Epilepsy: Starting With a Liquid Formulation in an Outpatient Setting. Child Neurol Open. 2018;5:2329048X18779497.

  6. Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia. 2017;58(2):e36-e39.

  7. Coppola G, Verrotti A, Ammendola E, Operto FF, Corte RD, Signoriello G et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol. 2010; 14(3):229–234.

  8. Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26(2):147-51.

  9. Ashrafi MR, Hosseini SA, Zamani GR, Mohammadi M, Tavassoli A, Badv RS et al. The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula- based powder. Acta Neurol Belg. 2017;117(1):175-182.

  10. Uldall P et al. Ketogenic diet for infants is possible with Ketocal. Epilepsia. 2006;47(S3):176.

  11. Rubenstein JE. Use of the ketogenic diet in neonates and infants. Epilepsia. 2008;49(Suppl 8):30-32.

  12. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008;23(7):758-61.

  13. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from populationbased clinical and seruvey data. Epilepsia 2000:41:341-351.

  14. Kossoff E et al. When do seizures usually improve with the ketogenic diet? Epilepsia. 2008;49:329-333.

  15. Englot DJ, Chang EF, Auguste KI. Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg. 2011;115(6):1248-55.

  16. Chambers A, Bowen JM. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(18):1-37.

  17. Cukiert A. Vagus Nerve Stimulation for Epilepsy: An Evidence-Based Approach. Prog Neurol Surg. 2015;29:39-52 18. Kossoff EH et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 Jun; 3(2): 175–192.

 

Referência: Na falha do 2º fármaco antiepilético (FAE), escolha a terapia mais eficaz.

 

  1. Sampaio LPB, Takakura C, Manreza, MLG. The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. NeuroPsiquiatr. 2017;75(4):234-237.

  2. Weijenberg A, van Rijn M, Callenbach PMC, de Koning TJ, Brouwer OF. Ketogenic Diet in Refractory Childhood Epilepsy: Starting With a Liquid Formulation in an Outpatient Setting. Child Neurol Open. 2018;5:2329048X18779497.

  3. Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia. 2017;58(2):e36-e39.

  4. Coppola G, Verrotti A, Ammendola E, Operto FF, Corte RD, Signoriello G et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol. 2010; 14(3):229–234.

  5. Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26(2):147-51.

  6. Ashrafi MR, Hosseini SA, Zamani GR, Mohammadi M, Tavassoli A, Badv RS et al. The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula- based powder. Acta Neurol Belg. 2017;117(1):175-182.

  7. Uldall P et al. Ketogenic diet for infants is possible with Ketocal. Epilepsia. 2006;47(S3):176.

  8. Rubenstein JE. Use of the ketogenic diet in neonates and infants. Epilepsia. 2008;49(Suppl 8):30-2.

  9. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008;23(7):758-61.

  10. Newton CR. Epilepsy in poor regions of the world. The Lancet. 2012; 380(9848):1193-1201.

  11. World Health Organization. Epilepsy Fact Sheet; 2015 [acesso em 08 jan 2020]. Disponível em: https://www.who.int/news-room/fact-sheets/detail/epilepsy.

  12. Engel J Jr. What can we do for people with drug-resitant epilepsy? The 2016 Warteberg Lecture. Neurology. 2016;87(23):2483-2489.

  13. Chen Z et al. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study. JAMA Neurol. 2018;75(3):279-286.

  14. Kossoff E et al. When do seizures usually improve with the ketogenic diet? Epilepsia.2008;49:329-333.

  15. Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and seruvey data. Epilepsia. 2000;41:341-351.

  16. Kossoff EH, Zupec-Kania BA, Amark PE, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R et al. Optimal Clinical Management of Children receiving the ketogenic diet: recommendations of the International ketogenic diet study group. Epilepsia. 2009;50(2):304-317.

  17. Sampaio LPB. ABC da dieta cetogênica para epilepsia refratária. Rio de Janeiro: Editora DOC Content, 2018. 1ª edição, 220 p.

  18. Uldall P et al. Ketogenic diet for infants is possible with Ketocal. Epilepsia. 2006;47(S3):176.

  19. Zamberlan P et al. Nutrição enteral em pediatria. Pediatria Moderna. 2002; 38(4):105-124.

  20. Kayyali HR. Luniova A, Abdelmoity A. Ketogenic diet decreases emergency room visits and hospitalizations related to epilepsy. Epilepsy Res Treat. 2016;5873208:1-4.

  21. Gilbert DL, Pyzik PL, Vining EP, Freeman JM. Medication cost reduction in children on the ketogenic diet: data from a prospective study. J Child Neurol. 1999; 14(7):469-71.

  22. Mandel A, Ballew M, Pina-Garza JEP, Stalmasek V, Clemens LH. Medical costs are reduced when children with intractable epilepsy are successfully treated with the ketogenic diet J Am Diet Assoc 2002,102:396-398.

 

Referências: O que é dieta cetogênica?

 

  1. Sampaio LPB. ABC da dieta cetogênica para epilepsia refratária. Rio de Janeiro: Editora DOC Content, 2018. 1a edição, 220 p.

  2. Kossoff EH et al. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018 Jun; 3(2): 175–192.

  3. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500-6.

  4. Keende DL. A systemaic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006;35:1-5.

  5. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000: 105; E46.

  6. Hallbook T, Lundgren J, Rosen I. Ketogenic diets impoves sleep quality in children with therapy-resistant epilepsy. Epilepsia. 2007; 48(1):59-65.

  7. Hallbook T, Sunggoan J, Maudsley S, Martin B. The effects of the ketogenic diet on behaviour and cognition. Epilepsy Res. 2012;100(3):304-9.

  8. Bruce S, Devlin A, Air L, Cook L. Changes in quality of life as a result of ketogenic diet therapy: A new approach to assessment with the potential for positive therapeutic effects. Epilepsy Behav. 2017;66:100-104.

  9. Sampaio LPB, Takakura C, Manreza, MLG. The use of a formula-based ketogenic diet in children with refractory epilepsy. Arq. NeuroPsiquiatr. 2017;75(4):234-237.

  10. Weijenberg A, van Rijn M, Callenbach PMC, de Koning TJ, Brouwer OF. Ketogenic Diet in Refractory Childhood Epilepsy: Starting With a Liquid Formulation in an Outpatient Setting. Child Neurol Open. 2018;5:2329048X18779497.

  11. Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia. 2017;58(2):e36-e39.

  12. Coppola G, Verrotti A, Ammendola E, Operto FF, Corte RD, Signoriello G et al. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur J Paediatr Neurol. 2010; 14(3):229–234.

  13. Kossoff EH, Dorward JL, Turner Z, Pyzik PL. Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month. J Child Neurol. 2011;26(2):147-51.

  14. Ashrafi MR, Hosseini SA, Zamani GR, Mohammadi M, Tavassoli A, Badv RS et al. The efficacy of the ketogenic diet in infants and young children with refractory epilepsies using a formula- based powder. Acta Neurol Belg. 2017;117(1):175-182.

  15. Uldall P et al. Ketogenic diet for infants is possible with Ketocal. Epilepsia. 2006;47(S3):176.

  16. Rubenstein JE. Use of the ketogenic diet in neonates and infants. Epilepsia. 2008;49(Suppl 8):30-2.

  17. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008;23(7):758-61.

  18. Sampaio LPB. ABC da dieta cetogênica para epilepsia refratária. Rio de Janeiro: Editora DOC Content, 2018. 1a edição, 220 p.

  19. van der Louw E et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol. 2016 Nov;20(6):798-809.

  20. Caraballo R, Vaccarezza M, Cersósimo R, Rios V, Soraru A, Arroyo H et al. Long-term follow- up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure. 2011;20(8):640-5.

  21. Worden LT, Turner Z, Pyzik PL, Rubenstein JE, Kossoff EH. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res. 2011;95(3):232-6.

  22. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008; 7(6):500-6.

  23. Keende DL. A systemaic review of the use of the ketogenic diet in childhood epilepsy. Pediatr Neurol. 2006;35:1-553.

  24. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000;105: E46.

  25. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database of Syst Rev. 2016;2:CD001903.

  26. Berkel AA, Ijff DM, Verkuyl JM. Cognitive benefits of the ketogenic diet in patients with epilepsy: A systematic overview. Epilepsy Behav. 2018;87:69-77.

 

Aptamil AR – Referências lâmina setembro 2020

 

  1. HCPTRACKER 2019.

  2. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  3. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e Docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.

  4. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  5. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  6. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  7. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-.

  8. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  9. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  10. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  11. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em agosto de 2020.

  12. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  13. Tounian P, et al. Tolerance and efficacy of a locust bean gum-thickened formula for reduction of infantile regurgitation. PGHN 2020 (in press).

  14. Feferbaum R, Falcão MC, eds. Nutrição do recém-nascido. São Paulo: Editora Atheneu, 2003.

  15. Comparativo de produtos de mesma categoria realizado em agosto de 2020.

 

Referências – Active setembro 2020

 

  1. Savino F et al. Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr 2006, 60:1304-10.

  2. Savino F et al. Advances in the management of digestive problems during the first months of life. Acta Paediatr Suppl 2005, 94:120.

  3. Morais, M.B. Signs and symptoms associated with digestive tract development. J Pediatr (Rio J). 2016;. 92(3 Suppl 1):S46-56.

  4. Benninga MA et al. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology 2016;150:1443–1455.

  5. Vandenplas Y et al. Algorithms for managing infant constipation, colic, regurgitation and cow’s milk allergy in formula-fed infants. Acta Pædiatrica 2015, ISSN 0803-5253.

  6. Vandenplas, Y et al. Functional gastrointestinal disorders in infancy: impact on the health of the infant and Family. Pediatr Gastroenterol Hepatol Nutr, 2019.

  7. HCP TRACKER 2019.

  8. Morais. J Ped (Rio J).2016;92(Suppl 1):S46-S56.

  9. Schmulson MJ, Drossman DA 2017.

  10. Bellaiche M., et al. Acta Pædiatrica 2018 107, pp. 1276–1282.

  11. Bellaiche M., et al. Acta Paediatrica. 2020;00:1–8.

  12. Salvatore S., et al. Review shows that parental reassurance and nutritional advice help to optimise the management of functional gastrointestinal disorders in infants. Acta Pædiatrica 2018 107, pp. 1512–1520.

  13. Vandenplas Y et al. Middle East Consensus Statement on the Diagnosis and Management of Functional Gastrointestinal Disorders in <12 Months Old Infants. Pediatr Gastroenterol Hepatol Nutr 2016 September 19(3):153-161.

  14. Schmelzle H et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 2003, 36:343-51.

  15. Savino F et al. “Minor” feeding problems during the first months of life: effect of a partially hydrolyzed milk formula containing fructo- and galacto-oligosaccharides. Acta Paediatr Suppl 2003, 91:86-90.

  16. Meyer, R. et al. Systematic review of the impact of feed protein type and degree of hydrolysis on gastric emptying in children. BMC Gastroenterol. 2015.

  17. Bongers ME et al. The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial. Nutr J 2007;6:8.

  18. Havlicekova Z et al. Beta-palmitate - a natural component of human milk in supplemental milk formulas. Nutr J. 2016;15(1):28.

  19. Litmanovitz I et al. Reduced crying in term infants fed high beta-palmitate formula: a double-blind randomized clinical trial. BMC Pediatr. 2014;14:152.

  20. Yao M et al. Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity. J Pediatr Gastroenterol Nutr. 2014 ;59(4):440-8.

  21. Nowacki J et al. Stool fatty acid soaps, stool consistency and gastrointestinal tolerance in term infants fed infant formulas containing high sn-2 palmitate with or without oligofructose: a double-blind, randomized clinical trial. Nutr J. 2014;13:105.

  22. Moro G et al. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291-5.

  23. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238–225.

  24. Boehm G et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004; 38: S76-9.

  25. Vandenplas Y et al. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br J Nutr. 2015;113(9):1339-44.

  26. Oozeer R et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr. 2013;98(2):561S-71S.

  27. Comparativo de produtos de mesma categoria realizado em agosto de 2020.

  28. Gordon M, et al. Dietary modifications for infantile colic. Cochrane Database of Systematic Reviews 2018, Issue 10. Art. No.: CD011029.

 

Aptamil AR – Referências página final Monografia digital – junho 2020

 

  1. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  2. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  3. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  4. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  5. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  6. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  7. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  8. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  9. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  10. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  11. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  12. Comparativo de produtos de mesma categoria realizado em abril de 2020.

 

Aptamil AR – Referências página final Monografia impressa – junho 2020

 

  1. HCPTRACKER 2019.

  2. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  3. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  4. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  5. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  6. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  7. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  8. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  9. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  10. Comparativo de produtos de mesma categoria realizado em abril de 2020.

  11. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  12. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  13. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

 

Referências: Lâmina de lançamento Aptamil AR farmacêutico

 

  1. HCPTRACKER 2019.

  2. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  3. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e Docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  4. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  5. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  6. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  7. Comparativo de produtos de mesma categoria realizado em abril de 2020.

  8. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  9. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  10. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  11. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  12. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

 

Aptamil AR – Referências para o VA de lançamento – ABRIL 2020

 

  1. HCPTRACKER 2019.

  2. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  3. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  4. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  5. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  6. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  7. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  8. Kus MMM, Mancini-Filho J. Ácidos Graxos – Eicosapentaenóico (EPA) e Docosahexaenóico (DHA): Funções Plenamente Reconhecidas de Nutrientes – ILSI Brasil. Volume 17, 2010.

  9. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  10. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

  11. Dupont C. Protein requirements during the first year of life. Am J Clin Nutr. 2003;77(6):1544S-1549S.

  12. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  13. Relatório de uso interno Danone Nutricia – Acesso: Junho/2020.

  14. Comparativo de produtos de mesma categoria realizado em Junho de 2020.

 

Aptamil AR – Referências para o VA farmacêutico – ABRIL 2020

 

  1. Relatório de uso interno Danone Nutricia – Acesso: Abril/2020.

  2. Koletzko B et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med. 2008;36(1):5-14.

  3. Ballard O, Morrow AL. Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am.2013;60(1):49-74.

  4. Infante Pina D et al. Thickened infant formula, rheological study of the “in vitro” properties. An Pediatr (Barc). 2010; 72(5):302-8.

  5. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  6. Wenzl TG et al. Effects of thickened feeding on gastroesophageal reflux in infants: a placebo-controlled crossover study using intraluminal impedance. Journal of Pediatrics, 2003;111(4):355-359.

  7. Salvatore S. at el. Tickened infant formula: what to know. Nutrition 49 (2018) 51-56.

  8. Danone Nutricia Research: https://www.nutriciaresearch.com. Acesso em janeiro de 2020.

  9. Comparativo de produtos de mesma categoria realizado em março de 2020.

  10. Meunier L et al. Locust bean gum safety in neonates and young infants: an integrated review of the toxicological database and clinical evidence. Regul Toxicol Pharmacol. 2014;70(1):155-69.

  11. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

 

Referências – Banner digital Brasileiro de Pediatria

 

  1. Vandenplas Y et al. Prevalence and Health Outcomes of Functional Gastrointestinal Symptoms in Infants from Birth to 12 Months of Age. J Pediatr Gastroenterol Nutr 2015b;61:531-7.

  2. Bellaiche M. et al. Multiple functional gastrointestinal disorders are frequent in formula-fed infants and decrease their quality of life. Acta Pædiatrica 2018 107, pp. 1276–1282.

  3. Benninga MA et al. Childhood Functional Gastrointestinal Disorders: Neonate/Toddler. Gastroenterology 2016;150:1443–1455.

  4. Vandenplas Y et al. Algorithms for managing infant constipation, colic, regurgitation and cow’s milk allergy in formula-fed infants. Acta Pædiatrica 2015, ISSN 0803-5253.

  5. Rachel R et al. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. JPGN Volume 66, Number 3, March 2018.

  6. Borrelli O et al. Use of a new thickened formula for treatment of symptomatic gastroesophageal reflux in infants. Ital J Gastroenterol Hepatol, 1997; 29:237-42.

  7. Savino F et al. Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr 2006, 60:1304-10.

  8. Simakachorn N et al. Randomized, double-blind clinical trial of a lactose-free and a lactose-containing formula in dietary management of acute childhood diarrhea. J Med Assoc Thai. 2004 Jun;87(6):641-9.

  9. Comparativo dos produtos da mesma categoria no mercado realizada em setembro de 2019 10. 13 - HCPTRACKER 2019 11. - Koletzko B et al. The roles.

 

Referências vídeos pílulas Dr. Ivo Prola

 

  1. Wegh C.A.M et al. The Effect of Fiber and Prebiotics on Children's Gastrointestinal Disorders and Microbiome. Expert Rev Gastroenterol Hepatol. 2017 Nov;11(11):1031-1045.

  2. Schmelzle, H. et al. Randomized Double-Blind Study of the Nutritional Efficacy and Bifidogenicity of a New Infant Formula Containing Partially Hydrolyzed Protein, a High Beta-Palmitic Acid Level, and Nondigestible Oligosaccharides. J Pediatr Gastroenterol Nutr. 2003 Mar;36(3):343-51.

  3. Savino, F et al. Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula. European Journal of Clinical Nutrition volume 60, pages1304–1310(2006).

  4. Rinne, M.M. et al. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunology & Medical Microbiology, Volume 43, Issue 1, January 2005, Pages 59–65.

  5. Vandenplas,Y. et al. Prebiotics in infant formula. Gut Microbes 5:6, 681--687; November/December 2014.

  6. Skórka A. et al. Infant formulae supplemented with prebiotics: Are they better than unsupplemented formulae? An updated systematic review. The British Journal of Nutrition, 18 Feb 2018, 119(7):810-825.

  7. Mihatsch, W.A. et al. Hydrolysed Protein Accelerates the Gastrointestinal Transport of Formula in Preterm Infants. Acta Paediatr. 2001 Feb;90(2):196-8.

  8. Savino, F. et al. “Minor” feeding problems during the first months of life: effectof a partially hydrolysed milk formula containing fructo- and galactooligosaccharides. Acta Pædiatr 2003; Suppl 441: 86–90.

  9. Bellaiche, M. et al. Multiple functional gastrointestinal disorders are frequent in formula-fed infants and decrease their quality of life. Acta Pædiatrica 2018 107, pp. 1276–1282.

  10. Bergmann, M.M. et al. Common Colic, Gastroesophageal Reflux and Constipationin Infants Under 6 Months of Age Do Not Necessitatean Allergy Work- Up Pediatr Allergy Immunol. 2014 Jun;25(4):410-2..

  11. Schmulson, M. J. et al. What Is New in Rome IV. J Neurogastroenterol Motil. 2017 Apr; 23(2): 151–163.

  12. Morais, M.B. Signs and symptoms associated with digestive tract development. J Pediatr (Rio J). 2016;. 92(3 Suppl 1):S46-56.

  13. Salvatore, S. et al. Thickened Infant Formula: What to Know.Nutrition. 2018 May;49:51-56.

  14. Pina, D. I. et al. Estudio del comportamiento reológico in vitro de las fórmulas antirregurgitación. Anales de Pediatría. Vol. 72. Núm. 5.páginas 302- 308 (Mayo 2010).

  15. Vandenplas, Y. et al. Functional Gastrointestinal Disorders in Infancy: Impact on the Health of the Infant and Family. Pediatr Gastroenterol Hepatol Nutr. 2019 May; 22(3): 207–216.

  16. Biagioli, E. et al. Pain-relieving Agents for Infantile Colic. Cochrane Database Syst Rev. 2016 Sep 16;9(9):CD009999.

  17. Laranjeira M et al. Adequado crescimento, ausência de ganho de peso excessivo e de alteração no padrão evacuatório em lactentes com refluxo gastroesofágico recebendo fórmula infantil espessada com goma jataí. Pediatr. Mod. 2014; 50(8): 339-342.

 

Referências – Caixa de Amostra + Régua de Crescimento Aptanutri

 

  1. Liu L et al. Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets. J Lipid Res. 2014;55(3):531-9.

  2. Wijendran V et al. Efficacy of dietary arachidonic acid provided as triglyceride or phospholipid as substrates for brain arachidonic acid accretion in baboon neonates. Pediatr Res. 2002;51(3):265-72.

  3. Brown, TT; Jernigan T.L.Brain devolopment during the preschool years. Neuropsychol Rev. 2012 December ; 22(4): 313–333.

  4. FAO. Food and Agriculture Organization of the Unite Nations (FAO). Fats and fatty acids in human nutrition. Rome, 2010. Report of an expert consultation. Food and Nutrition Paper 91.

  5. Suthutvoravut U et al. Composition of Follow-Up Formula for Young Children Aged 12–36 Months: Recommendations of an International Expert Group Coordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Ann Nutr Metab 2015;67:119–132.

  6. Harmsen H, Wildeboer-Veloo A, Raangs G, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30(1):61-67.

  7. Bar-Yoseph F et al. Review of sn-2 palmitate oil implications for infant health. Prostaglandins Leukot Essent Fatty Acids. 2013;89(4):139-43.

  8. Agostoni C et al. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):465-73.

  9. Braegger C et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2011;52:238–225.

  10. Arslanoglu S et al. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008; 138(6): 1091-5.Martin CR et al. Review of Infant Feeding: Key Features of Breast Milk and Infant Formula. Nutrients. 2016;8(5). pii: E279.

  11. Moro GE et al. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatr Suppl. 2005;94(449):27-30.

  12. Knol J et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40(1):36-42.

  13. Bruzzese E et al. A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study. Clin Nutr. 2009;28(2):156-61.

  14. Boehm G et al. Prebiotics in infant formulas. J Clin Gastroenterol. 2004; 38: S76-9.

  15. Vandenplas Y et al. Oligosaccharides in infant formula: more evidence to validate the role of prebiotics. Br J Nutr. 2015;113(9):1339.

  16. Shahramian I, Kalvandi G, Javaherizadeh H, et al. The effects of prebiotic supplementation on weight gain, diarrhoea, constipation, fever and respiratory tract infections in the first year of life. J Paediatr Child Health. 2018;54(8):875-880.

  17. Mello CS, Barros KV, Morais MB. Alimentação do lactente e do pré-escolar brasileiro: revisão da literatura. J. Pediatr. 2016; 92 (5): 451-463.

  18. Comparativo de Produtos do Mercado de Fórmulas Infantis. Setembro 2020.

  19. Pietrobelli A, Agosti M. Nutrition in the First 1000 Days: Ten Practices to Minimize Obesity Emerging from Published Science.

  20. Nogueira-de-Almeida CA. Consensus of the Brazilian Association of Nutrology on Milky Feeding of Children Aged 1–5 Years Old. International Journal of Nutrology Vol. 13 No. 1/2020.

  21. SBP. Manual de Orientação do departamento de nutrologia: alimentação do lactente ao adolescente, alimentação na escola, alimentação saudável e vínculo mãe-filho, alimentação saudável e prevenção de doenças, segurança alimentar. 2012.

Referências  calendário 2021

PAG 10 – LINHA MILNUTRI

  1. Scharf RJ et al. Pediatr Rev. 2016;37(1):25-37;quiz 38, 47

PAG 11 – MILNUTRI

  1.  Agostoni C et al. J Pediatr Gastroenterol Nutr. 2008;46(1):99-110.
  2. Chatchatee P et al. JPGN. 2014;58:428–37
  3. Human Vitamin and Mineral Requirements. FAO, 2001.
  4. Suthutvoravut U et al. Ann Nutr Metab. 2015;67(2):119-32.
  5. Oozeer R et al. Am J Clin Nutr. 2013; 98 (suppl): 561S-71S.
  6. Wopereis H et al. Pediatr Allergy Immunol 2014.

PAG 23 – MILNUTRI

  1. Graf et al. Leukotrienes and Essential Fatty Acids (PLEFA). 2010; 83 (2): 89-96
  2. Liu L et al. J Lipid Res. 2014;55(3):531-9.
  3. Wijendran V et al. Pediatr Res. 2002;51(3):265-72
  4. Dado de Mercado. Novembro 2020

PAG 24/25 – APTANUTRI

  1. Agostoni C et al. J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):465-73.
  2. ANVISA. RDC 44, de 19 de setembro de 2011.
  3. Bailey RL et al. Ann Nutr Metab. 2015;66 Suppl 2:22-33
  4. Ballard O et al. Pediatr Clin North Am. 2013;60(1):49-74.
  5. Bar-Yoseph F et al. Prostaglandins Leukot Essent Fatty Acids. 2013;89(4):139-43.
  6. Braegger C et al. J Pediatr Gastroenterol Nutr. 2011;52:238–225.
  7. Brown TT et al. Neuropsychol Rev. 2012; 22(4):313–333
  8. Cominetti C et al. Zinco. ILSI Brasil, 2009; n.7
  9. Dado de Mercado. Novembro 2020
  10. FAO. Fats and fatty acids in human nutrition. Rome, 2010. Food and Nutrition Paper 91
  11. Fisberg M et al. Ferro. ILSI Brasil, 2008; n.3.
  12. Graf et al. Leukotrienes and Essential Fatty Acids (PLEFA). 2010; 83 (2): 89-96
  13.  Harmsen H et al. J Pediatr Gastroenterol Nutr. 2000;30(1):61-67
  14. Liu L et al. J Lipid Res. 2014;55(3):531-9.
  15. Mello CS et al. J Pediatr(Rio J). 2016;92:451-63.
  16. Merritt RJ et al. JPGN. 2020; 71(2).
  17. Nogueira-de-Almeida CA. International Journal of Nutrology. 2020; 13 (1).
  18. Peters B. Vitamina D. ILSI Brasil, 2014.
  19. Pietrobelli A et al. Nutrition in the First 1000 Days: Ten Practices to Minimize Obesity Emerging from Published Science.
  20. Prado EL et al. Nutr Rev. 2014;72(4):267-84.
  21. Ramalho A. Vitamina A. ILSI Brasil, 2010; n.12
  22. SBP. 2012
  23. Suthutvoravut U et al. Ann Nutr Metab 2015;67:119–132
  24. Vannucchi H et al. Ácido ascórbico (vitamina C). ILSI Brasil, 2012; n.21
  25. Wijendran V et al. Pediatr Res. 2002;51(3):265-72
  26. Finn S et al. Sci Prog. 2018;101:332-59
  27. Weffort V et al. In: 39 º Congresso Brasileiro de Pediatria, 2019, Porto Alegre.
  28. Maranhão H et al. In: 39 º Congresso Brasileiro de Pediatria, 2019, Porto Alegre.
  29. Morais M et al. In: 39 º Congresso Brasileiro de Pediatria, 2019, Porto Alegre.
  30. Carvalho CA et al. Rev Paul Pediatr. 2015; 33(2):211-221.
  31. Oozeer R et al. Am J Clin Nutr. 2013;98(2):561S-71S
  32. Liu L et al. J Lipid Res. 2014;55(3):531-9.
  33. EFSA NDA Panel. EFSA Journal. 2014; 12(10):38404.
  34. Willatts P et al. The Lancet. 1998; 352:688-91
  35. Bouwstra H et al. Am J Clin Nutr. 2003; 78(2): 313-8.
  36. Moro G et al. J Pediatr Gastroenterol Nutr. 2002;34(3):291-5.
  37. Moro G et al. Acta Paediatr Suppl. 2005;94(449):27-30.
  38. Knol J et al. J Pediatr Gastroenterol Nutr. 2005;40(1):36-42.
  39. Scholtens PA et al. World J Gastroenterol. 2014;20(37):13446-52.
  40. Stahl B et al. Anal Biochem. 1994;223(2):218-26
  41. Boehm G et al. J Clin Gastroenterol. 2004; 38: S76-9
  42. Vandenplas Y et al. Br J Nutr. 2015;113(9):1339-44.
  43. Bruzzese E et al. Clin Nutr. 2009;28(2):156-61.
  44. Wopereis H et al. Pediatr Allergy Immunol. 2014;25:428–438.
  45. Chistiakov DA et al. Front Microbiol. 2015; 13(5):781-9.
  46. Round JL et al. Nat Rev Immunol. 2009;9(5):313-23.
  47. Havlicekova Z et al. Nutr J. 2016;15(1):28.
  48. Miles EA, Calder PC. Nutrition Research 44(2017) 1-8.
  49. Kabaran S et al. Matern Child Nutr. 2011;7 Suppl 2:112-23.
  50. Pedersen L et al. Pediatr Res. 2012;72(6):631-6.
  51. Liu L et al. J Lipid Res. 2014;55(3):531-9.
  52. Yao M et al. J Pediatr Gastroenterol Nutr. 2014;59(4):440-8.
  53. Nowacki J et al. Nutr J. 2014;13:105

Milnutri Complete

  1. Kerzner B, Milano K, MacLean WC Jr, Berall G, Stuart S, Chatoor I. A Practical Approach to Classifying and Managing Feeding Difficulties. Pediatrics. 2015; 135(2):344-53
  2. Fisberg M, Maximino P. Dificuldades Alimentares. In: Nogueira-de-Almeida CA, Mello ED. Nutrologia Pediátrica: Prática Baseada em Evidências. Barueri: Manole; 2016. 117-25.
  3. IOM - Institute of Medicine. Dietary Reference Intakes - The Essential Guide to Nutrient Requirements. Washington: The National Academies Press; 2006. 69-413.
  4. FAO – Food and Agriculture Organization of United Nations. Fats and fatty acids in human nutrition: report of an expert consulation. Geneva: Food and Nutrition Paper; 2010. 91.
  5. Comparativo de tabela nutricional de produtos da mesma categoria no mercado, realizado em Dezembro de 2019.

Fortini

  1. Comparativo entre suplemento normocalórico (1,0kcal/mL) e Fortini
  2. Giugliani ER, Victoria CG. Complementary Feeding. J Pediatr (Rio J) 2000;76(Supl.3):S253-S62.
  3. SBP - Sociedade Brasileira de Pediatria. Manual de orientação do departamento de nutrologia. Departamento Científico de Nutrologia Sociedade Brasileira de Pediatria. 2012. p 81.
  4. Shaw V, Lawson M. Clinical Paediatric Dietetics. 2nd edition. London: Blackwell Science; 2011.

Neoforte (páginas 6 e 7)

  1. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução nº 269, de 22 de setembro de 2005. Dispõe sobre o regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. Diário Oficial da União. 23 set 2005
  2. Saad, SMI. Probióticos  e prebióticos: o estado de arte. Rev. Bras. Cienc. Farm. vol.42 no.1 São Paulo Jan./Mar. 2006
  3. Maslin K, Dean T, Arshd SH, Venter C. Fussy eating and feeding difficulties in infants and toddlers consuming a cow´s milk exclusion diet. Pediatr Allergy Immunol. 2015;26(6):503
  4. Solé D, Silva LR, Cocco RR, Ferreira CT, Sarni RO, Oliveira LC et al. Consenso brasileiro sobre alergia alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82)

Linha Neo (páginas 14 e 15)

  1. Medeiros, LSC; Speridiao PGL; Sdepanian VL et al. Ingestão de nutrientes e estado nutricional de crianças em dieta isenta de leite de vaca e derivados. J Pediatr (Rio J). 2004;80(5):363-70.
  2. Canani RB, Ludovica Leone LDN, D’Auria E. et al. The Effects of Dietary Counseling on Children with Food Allergy: A Prospective, Multicenter Intervention Study. J Acad Nutr Diet. 2014 Sep;114(9):1432-9
  3. Meyer R; Wright K; Vieira MC et al. International survey on growth indices and impacting factors in children with food allergies. (2018) International survey on growth indices and impacting factors in children with food allergies. J Hum Nutr Diet
  4. Singhal S; Baker RD; Baker SS. A Comparison of the Nutritional Value of Cow’s Milk and Nondairy Beverages. JPGN Volume 64, Number 5, May 2017
  5. Boaventura RM, Mendonça RB, Fonseca FA et al. Nutritional Status and food intake of children with cow´s milk allergy. Allergol Immunopathol (Madr). 2019
  6. Solé D, Silva LR, Cocco RR, Ferreira CT, Sarni RO, Oliveira LC et al. Consenso brasileiro sobre alergia alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82

Neo Advance (pág 17)

  1. Solé D, Silva LR, Cocco RR, Ferreira CT, Sarni RO, Oliveira LC et al. Consenso brasileiro sobre alergia alimentar: 2018 – Parte 1 e 2. Arq Asma Alerg Imunol. 2018;2(1):7-82
  2. Sociedade Brasileira de Pediatria (SBP). Manual de orientação do Departamento de Nutrologia. Alimentação do lactente ao adolescente, alimentação na escola, alimentação saudável e vínculo mãe-filho, alimentação saudável e prevenção de doenças, segurança alimentar. Rio de Janeiro: Sociedade Brasileira de Pediatria. 3ed. 2012. 152p
  3. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução nº 269, de 22 de setembro de 2005. Dispõe sobre o regulamento técnico sobre a ingestão diária recomendada (IDR) de proteína, vitaminas e minerais. Diário Oficial da União. 23 set 2005
  4. Institute of Medicine (IOM). Dietary Reference Intake (DRI) for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Washington (DC). The National Academies Press. 2005. 1332p
  5. Braegger C, Decsi T, Dias JA, Hartman C, Kolacek S, Koltzko B et al. Pratical approach to paediatric enteral nutrition: a comment by the ESPGHAN committee on Nutrition. J Parenter Enteral Nutr. 2010;51:110-22
  6. Maslin K, Dean T, Arshd SH, Venter C. Fussy eating and feeding difficulties in infants and toddlers consuming a cow´s milk exclusion diet. Pediatr Allergy Immunol. 2015;26(6):503
  7. Maslin K et al. Dietary variety and food group consumption in children consuming a cows’ milk exclusion diet. Pediatr Allergy Immunol. 2016 Aug;27(5):471-7.
  8. Maslin K et al. Taste preference, food neophobia and nutritional intake in children consuming a cows’ milk exclusion diet: a prospective study. J Hum Nutr Diet. 2016 Dec;29(6):786-796.

PAG 18/19 KETOCAL

  1. Sampaio LPB et al. Arq. NeuroPsiquiatr. 2017;75(4):234-237.
  2. Weijenberg A et al. Child Neurol Open. 2018;5:2329048X18779497.
  3. Thompson L et al. Epilepsia. 2017;58(2):e36-e39.
  4. Coppola G et al. Eur J Paediatr Neurol. 2010; 14(3):229–234.
  5. Kossoff EH et al. J Child Neurol. 2011;26(2):147-51.
  6. Ashrafi MR et al. Acta Neurol Belg. 2017;117(1):175-182.
  7. Uldall P et al. Epilepsia. 2006;47(S3):176.
  8. Rubenstein JE. Epilepsia. 2008;49(Suppl 8):30-2.
  9. Nizamuddin J et al. J Child Neurol. 2008;23(7):758-61.
  10. Henderson CB et al. J Child Neurol. 2006;21:193-8.
  11. Keene DL. Pediatr Neurol. 2006;35:1-5.
  12. Lefevre F et al. Pediatrics. 2000;105:E46.
  13. Gilbert DL et al. J Child Neurol. 1999; 14(7):469-71.
  14. Mandel A et al. J Am Diet Assoc 2002,102:396-398.
  15. Kayyali HR et al. Epilepsy Res Treat. 2016;5873208:1-4
  16. Blackford R. Epilepsy Res. 2020;162:106307
  17. Kossoff EH et al. Epilepsia Open. 2018; 3(2): 175–192.
  18. Sampaio LPB. ABC da dieta cetogênica para epilepsia refratária. Rio de Janeiro: Editora DOC Content, 2018. 1a edição, 220 p.
  19. van der Louw E et al. Eur J Paediatr Neurol. 2016;20(6):798-809.
  20. Berkel AA et al. Epilepsy Behav. 2018;87:69-77

PEDIATRIA HOSPITALAR

  1. Pratical Approch to Paediatric Enteral Nutrition: A Comment by the ESPGHAN Committee on Nutrition (JPGN Volume 51, Number 1, July 2010).
  2. Nutrição Enteral em Pacientes Pediátricos. Documento Científico. Departamento Científico do Suporte Nutricional. Sociedade Brasileira de Pediatria. Nº 4, Março de 2018.